$500.03
19081 reports the first lesion biopsied with stereotactic guidance; 19082 reports each additional lesion sampled with that guidance.
On this page
CMS RVU26D · Effective 2026-10-01
19082 Breast biopsy Medicare reimbursement rates in Colorado
Reports percutaneous biopsy of an additional breast lesion sampled with stereotactic guidance during an encounter that includes the primary lesion biopsy. Compare 19082 office and facility rates across CMS payment localities in Colorado.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 19082 in Colorado?
Colorado has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$382.26
1 of 1 localities have a supported rate.
Payment area: Colorado
One mapped payment locality.
Facility setting
$69.52
1 of 1 localities have a supported rate.
Payment area: Colorado
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Breast imaging procedure
About 19082: Additional stereotactic breast biopsy lesion
Reports percutaneous biopsy of an additional breast lesion sampled with stereotactic guidance during an encounter that includes the primary lesion biopsy.
This add-on code covers percutaneous needle sampling of an additional breast lesion using stereotactic imaging to guide the biopsy. A radiologist or breast surgeon typically performs the procedure in a breast imaging center, outpatient department, or office equipped for stereotactic biopsy. Localization-device placement and imaging of the specimen are included when performed. The additional lesion must be distinct from the lesion reported with the primary biopsy.
Report 19082 with 19081 for each additional lesion biopsied using stereotactic guidance; it is not reported by itself. Documentation should identify the separately sampled lesion and support stereotactic guidance, with separate specimen labeling or pathology identification when applicable. CMS treats 19082 as an add-on billed with a primary procedure, and its payment falls within that primary procedure's global period.
CMS billing rules for 19082
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
Where the value comes from
- Work RVU1.61 · 15%
- Practice expense (office) RVU9.10 · 84%
- Malpractice RVU0.17 · 2%
4.2K
Medicare services in 2024 · #1982 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
19082 compared with similar codes
Office rates for Colorado, from the same CMS release.
$376.13
Both are add-on codes for an additional lesion, but 19084 uses ultrasound guidance rather than stereotactic guidance.
$583.84
19086 reports an additional lesion sampled with MRI guidance; 19082 is for stereotactic guidance.
$497.61
19083 is the first-lesion code for ultrasound-guided biopsy. For an additional lesion, ultrasound guidance points to 19084 instead.
Compare 19082 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Colorado →
Office / nonfacility
$382.26
Facility
$69.52
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 19082 in Colorado.
PPRRVU2026_Oct_nonQPP.csv
1,660
- Code
- 19082
- Physician work
- 1.61
- Practice expense
- 9.10
- Malpractice
- 0.17
GPCI2026.csv
37
- Locality
- Colorado
- Physician work
- 1.012
- Practice expense
- 1.064
- Malpractice
- 0.781
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 1.61 | × 1.012 | 1.6293 |
| Practice expense | 9.10 | × 1.064 | 9.6824 |
| Malpractice | 0.17 | × 0.781 | 0.1328 |
| Total RVUs | 11.4445 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Colorado$382.26
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 1.61 | 1.012 |
| Practice expense | 9.1 | 1.064 |
| Malpractice | 0.17 | 0.781 |
(1.61 × 1.012 + 9.1 × 1.064 + 0.17 × 0.781) × $33.4009 = $382.26
Facility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 1.61 | 1.012 |
| Practice expense | 0.3 | 1.064 |
| Malpractice | 0.17 | 0.781 |
(1.61 × 1.012 + 0.3 × 1.064 + 0.17 × 0.781) × $33.4009 = $69.52
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
19082 billing questions
When should 19082 be reported instead of 19081?
Use 19081 for the first lesion biopsied with stereotactic guidance. Report 19082 for each additional distinct lesion sampled with that guidance.
Can 19082 be billed by itself?
No. It is an add-on code and must be reported with the primary stereotactic breast biopsy, 19081.
Can the localization device or specimen imaging be billed separately?
Device placement and imaging of the specimen are included when performed as part of the biopsy described by this code.
What documentation supports reporting an additional lesion?
Record that a distinct additional breast lesion was sampled, the use of stereotactic guidance, and the specimen identification for each sampled site.
How does 19082 differ from 19084?
Both report an additional lesion, but 19082 is for stereotactic guidance and 19084 is for ultrasound guidance.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
1,65719020,,Mastotomy expl drg absc dp,A,,3.73,10.75,,4.82,,0.92,15.40,9.47,0,090,0.10,0.71,0.19,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,65819030,,Njx px only mam ducto/glcto,A,,1.49,3.13,,0.28,,0.15,4.77,1.92,0,000,0.00,0.00,0.00,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,65919081,,Bx breast 1st lesion strtctc,A,,3.21,10.76,,0.58,,0.35,14.32,4.14,0,000,0.00,0.00,0.00,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,66019082,,Bx breast add lesion strtctc,A,,1.61,9.10,,0.30,,0.17,10.88,2.08,0,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,66119083,,Bx breast 1st lesion us imag,A,,3.02,10.88,,0.55,,0.34,14.24,3.91,0,000,0.00,0.00,0.00,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,66219084,,Bx breast add lesion us imag,A,,1.51,9.03,,0.28,,0.16,10.70,1.95,0,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
1,66319085,,Bx breast 1st lesion mr imag,A,,3.55,17.62,,0.63,,0.35,21.52,4.53,0,000,0.00,0.00,0.00,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3401112,CA,69,VISALIA,1.017,1.096,0.536
3501112,CA,70,YUBA CITY,1.017,1.096,0.536
3601112,CA,75,REST OF CALIFORNIA,1.017,1.096,0.536
3704112,CO,01,COLORADO,1.012,1.064,0.781
3813102,CT,00,CONNECTICUT,1.020,1.077,1.210
3912202,DC,01,DC + MD/VA SUBURBS,1.054,1.178,1.113
4012102,DE,01,DELAWARE,1.005,0.988,0.899